ArticleAnimals : an open access journal from MDPI2026
Serum Osteocalcin and CTX-I in Fit-to-Race Thoroughbred Racehorses: Reference Intervals and Associations with Demographic, Training, and Lameness-Related Factors.
Article in Animals : an open access journal from MDPI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Musculoskeletal injury remains a major welfare and performance concern in Thoroughbred racing, and biomarkers for early risk stratification are of scientific interest. This multicentre observational cohort study characterised serum concentrations of two bone turnover markers, osteocalcin/BGLAP (OC) and C-terminal telopeptide of type I collagen (CTX-I), in 1359 fit-to-race Thoroughbred racehorses sampled across New South Wales, Victoria, and Western Australia. Biomarker distributions, population-wide percentile ranges, demographic and training-related associations, and short-term soundness outcomes were evaluated using nonparametric methods. Both markers were positively skewed, with population-wide percentile ranges (2.5-97.5 percentile) of 0.13-9.44 ng/mL for CTX-I and 0.02-7.25 ng/mL for OC; CTX-I varied substantially by jurisdiction, so this pooled range should not be interpreted as a clinical reference interval for individual horses. CTX-I varied significantly by age, jurisdiction, venue, and training surface, with markedly higher concentrations in New South Wales horses and lower concentrations associated with polytrack training, but did not predict lameness outcomes. OC concentrations were significantly higher in horses classified as lame at sampling and showed modest discriminatory ability for subsequent lameness in univariate analysis, with the strongest performance for persistent lameness at both 7 and 28 days; this association attenuated after adjustment for age, sex, state, and training surface. At an unadjusted operational threshold of approximately 1.24 ng/mL, OC achieved high negative predictive value for persistent lameness. These findings suggest OC may have scientific value as a potential rule-out screening marker for short-term soundness, warranting further investigation, while CTX-I appears more informative for characterising population-level skeletal turnover variation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.